A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
Status:
Terminated
Trial end date:
2018-10-02
Target enrollment:
Participant gender:
Summary
This study is an extension of study I8D-MC-AZES (NCT02245737), the AMARANTH study. The
purpose of this study is to evaluate the effectiveness of the study drug lanabecestat in
participants with early Alzheimer's disease dementia at the time of entry into study
I8D-MC-AZES.